The UnitedHealth Group Inc (UNH) Expected to Announce Quarterly Sales of $50.02 Billion

The UnitedHealth Group Inc (UNH) Expected to Announce Quarterly Sales of $50.02 Billion

According to Zacks, analysts expect that UnitedHealth Group will report full-year sales of $50.02 billion for the current year, with estimates ranging from $199.75 billion to $201.13 billion. For the next year, analysts expect that the firm will post sales of $216.93 billion per share, with estimates ranging from $211.41 billion to $220.8 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow UnitedHealth Group.

Equities analysts expect UnitedHealth Group Inc (NYSE:UNH) to report $50.02 billion in sales for the current quarter, according to Zacks. Seven analysts have made estimates for UnitedHealth Group’s earnings. The lowest sales estimate is $48.97 billion and the highest is $50.61 billion. UnitedHealth Group reported sales of $46.49 billion in the same quarter last year, which would suggest a positive year over year growth rate of 7.6%. The firm is scheduled to issue its next quarterly earnings results on Tuesday, July 18th.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm had revenue of $48.72 billion for the quarter, compared to analysts’ expectations of $48.21 billion. During the same period in the previous year, the firm posted $1.81 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year. A number of analysts have recently issued reports on UNH shares. Cantor Fitzgerald started coverage on shares of UnitedHealth Group in a report on Monday, February 6th. They set an “overweight” rating and a $200.00 price target for the company. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a report on Monday. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $188.00 price target for the company in a report on Thursday, March 2nd. Wells Fargo & Co reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, February 21st. Finally, Mizuho lifted their target price on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, April 18th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $182.65.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,000 shares of UnitedHealth Group stock in a transaction on Wednesday, April 19th. The shares were sold at an average price of $170.54, for a total value of $2,387,560.00. Following the transaction, the executive vice president now directly owns 31,993 shares in the company, valued at $5,456,086.22. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,310 shares of the business’s stock in a transaction dated Thursday, February 23rd. The stock was sold at an average price of $162.31, for a total transaction of $861,866.10. Following the transaction, the director now owns 60,175 shares in the company, valued at $9,767,004.25. The disclosure for this sale can be found here. Insiders have sold a total of 40,148 shares of company stock worth $6,806,849 over the last quarter. 1.65% of the stock is owned by company insiders. A number of hedge funds have recently added to or reduced their stakes in UNH. BlackRock Inc. increased its stake in shares of UnitedHealth Group by 2,188.4% in the first quarter. BlackRock Inc. now owns 68,633,762 shares of the healthcare conglomerate’s stock valued at $11,256,624,000 after buying an additional 65,634,528 shares during the period. Dodge & Cox acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $1,658,560,000. Norges Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $1,530,177,000. TPG Group Holdings SBS Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the first quarter valued at about $510,530,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $391,839,000. 86.67% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH) For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment